The company brings a comprehensive solution for Biotech and Pharma business development teams, clinical development team, investment bankers, investors, and life science consultants to track drug development, monitor competition, follow market trends, analyze clinical trials, and inform about recent developments of drug candidates. The company provides data to its customers from a cloud-based platform with SAAS (software as a service) subscription business model. The company also offers daily or weekly alerts on selected or customized topics of interest. Catailyst makes data actionable and affordable as it leverages many proprietary methods of artificial intelligence involving machine learning and natural language processing methods to read and analyze different forms of texts announced daily such as press releases, SEC filings and trial registrations.
Request a demo here: https://www.catailyst.ai/request-demo